Olema Pharmaceuticals, Inc. (OLMA) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $533.43M | +18.3% |
| 2024 | $450.98M | +62.8% |
| 2023 | $276.94M | +28.4% |
| 2022 | $215.65M | -27.1% |
| 2021 | $295.94M | -13.6% |
| 2020 | $342.72M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $533.43M | +18.3% |
| 2024 | $450.98M | +62.8% |
| 2023 | $276.94M | +28.4% |
| 2022 | $215.65M | -27.1% |
| 2021 | $295.94M | -13.6% |
| 2020 | $342.72M | — |